For chronic hypocalcemia, which therapy is recommended?

For chronic hypocalcemia, which therapy is recommended?

• A. Oral vitamin D and calcium supplementation
• B. IV calcium gluconate
• C. Calcitonin
• D. Phosphate binders

Answer: (A)

When dealing with chronic hypocalcemia, the long-term goal is to restore and maintain a normal calcium level by supplying calcium and ensuring adequate calcium absorption through vitamin D. In chronic conditions, especially if deficiency or impaired PTH action is involved, the body’s ability to convert vitamin D to its active form or to promote gut calcium absorption is reduced. Providing oral calcium along with active vitamin D bypasses these shortcomings and keeps calcium levels steady without the risks of repeated emergency treatment. Therefore, oral calcium supplementation paired with vitamin D is the appropriate, ongoing therapy. IV calcium gluconate is reserved for acute, symptomatic hypocalcemia, not chronic management. Calcitonin lowers calcium and isn’t a standard chronic therapy for hypocalcemia. Phosphate binders address phosphate control rather than directly correcting calcium deficiency and aren’t primary therapy for chronic hypocalcemia.

When dealing with chronic hypocalcemia, the long-term goal is to restore and maintain a normal calcium level by supplying calcium and ensuring adequate calcium absorption through vitamin D. In chronic conditions, especially if deficiency or impaired PTH action is involved, the body’s ability to convert vitamin D to its active form or to promote gut calcium absorption is reduced. Providing oral calcium along with active vitamin D bypasses these shortcomings and keeps calcium levels steady without the risks of repeated emergency treatment.

Therefore, oral calcium supplementation paired with vitamin D is the appropriate, ongoing therapy. IV calcium gluconate is reserved for acute, symptomatic hypocalcemia, not chronic management. Calcitonin lowers calcium and isn’t a standard chronic therapy for hypocalcemia. Phosphate binders address phosphate control rather than directly correcting calcium deficiency and aren’t primary therapy for chronic hypocalcemia.